Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual Therapy (RPV + DRV/r) vs Triple Therapy in Virologically Suppressed HIV
NCT01792570Phase 3Completed
- Sponsor
- ASST Fatebenefratelli Sacco
- Start
- Sep 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rilpivirine, darunavir in human immunodeficiency virus infection (HIV), sponsored by ASST Fatebenefratelli Sacco. Started Sep 2014; status: completed.
02
Drugs
rilpivirinedarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01792570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01792570.